L m a t Pharmaceutica Analytica Acta a e Comparision of in vitro and in vivo Research

Citation: Brake K, Gumireddy A, Tiwari A, Chauhan H, Kumari D (2017) In vivo Studies for Drug Development via Oral Delivery: Challenges, Animal Models and Techniques. Pharm Anal Acta 8:
560. doi:
10.4172/2153-2435.1000560
ISSN: 2153-2435
Volume 8 • Issue 8 • 1000560
Biopharmaceutics & Drug Disposition 16:351-380.
77. Zhang D, Luo G, Ding X, Lu, C (2012) Preclinical experimental models of drug
metabolism and disposition in drug discovery and development. Acta Pharmaceutica
Sinica B2: 549-561.
71. Lin JH (1995) Species similarities and differences in pharmacokinetics. drug
Can animal models of disease reliably inform human studies? PLoS med 7:
e1000245.
dissolution in IVIVC. Dissolution Technologies 14:p15.
Metabolism and Disposition 23:1008-1021.
Pharmacokinetics. 3:337-351.
39. Ensign LM, Cone R, Hanes J (2012) Oral drug delivery with polymeric nanoparticles:
The gastrointestinal mucus barriers. Advanced Drug Delivery Reviews 64: 557-570.
42. Won SC, Oberlies HN, Paine FM (2010) Influence of dietary substances on
intestinal drug metabolism and transport. current drug metabolism. 11: 778-792.
Council on Bioethics: 376.
74. Kararli TT (1995) Comparison of the gastrointestinal anatomy, physiology, and
biochemistry of humans and commonly used laboratory animals.
Xenobiotica 32: 165-206.
51. Barua S, Mitragotri S (2014) Challenges associated with penetration of nanoparticles
across cell and tissue barriers: A review of current status and prospects futures.
Nano Today 9: 223-243.
European Journal of Pharmaceutics and Biopharmaceutics 53: 301-309.
66. Lieschke GJ, Currie PD (2007) Animal models of human disease: Zebrafish
43. Melander A (1978) Influence of food on the bioavailability of drugs. Clinical
38. Rabanel J, Aoun V, Elkin I, Mokhtar M, Hildgen P (2012) Drug-loaded nanocarriers:
Passive targeting and crossing of biological barriers. Current Medicinal Chemistry
19: 3070-3102.
60 Van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, et al. (2010)
70. Sakai JB (2009) Practical pharmacology for the pharmacy technician.
56. Pelkmans L, Kartenbeck J, Helenius A (2001) Caveolar endocytosis of simian
virus 40 reveals a new two-step vesicular-transport pathway to the ER. 3:473-483.
48. Chrastina A, Massey KA, Schnitzer JE (2011) Overcoming in vivo barriers to
targeted nanodelivery. Wiley Interdisciplinary Reviews. Nanomedicine and
Nanobiotechnology 3: 421-437.
drug development. Handb Exp Pharmacol 232: 59-70.
54. Panyam J, Labhasetwar V (2003) Biodegradable nanoparticles for drug and gene
delivery to cells and tissue. Advanced Drug Delivery Reviews 55: 329-347.
41. Grassi M, Grassi G, Lapasin R, Colombo I (2006) Understanding drug release and
absorption mechanisms: A physical and mathematical approach: CRC Press.
73. Shojaei AH (1998) Buccal mucosa as a route for systemic drug delivery: A review.
J Pharm Pharm Sci 1: 15-30.
68. NCO (2005) The Ethics of Research Involving Animals London. Nuffield
33. Cardot J, Beyssac E, Alric M (2007) In vitro-in vivo correlation: Importance of
65. Zon LI, Peterson RT (2005) In vivo drug discovery in the zebrafish. Nature Reviews
Drug Discovery 4: 35-44.
58. Sirisuth N, Eddington ND (2002) The influence of first pass metabolism on the
development and validation of an IVIVC for metoprolol extended release tablets.
50. Owens DE, Peppas NA (2006) Opsonization, biodistribution, and pharmacokinetics
of polymeric nanoparticles. International Journal of Pharmaceutics 307: 93-102.
67. Kari G, Rodeck U, Dicker AP (2007) Zebrafish: An emerging model system for
human disease and drug discovery. Clinical Pharmacology & Therapeutics 82:
70-80.
53. Patel HM, Tuzÿel NS, Ryman BE (1983) Inhibitory effect of cholesterol on the
uptake of liposomes by liver and spleen. Biochimica et Biophysica Acta (BBA) -
General Subjects 761: 142-151.
37. Pridgen EM, Alexis F, Farokhzad OC (2015) Polymeric nanoparticle drug delivery
technologies for oral delivery applications. Expert opinion on drug delivery 12:
1459-1473.
79. Gibson G, Plant N, Swales K, Ayrton A, El-Sankary W (2002) Receptor dependent
transcriptional activation of cytochrome P4503A genes: Induction mechanisms,
species differences and interindividual variation in man.
47. Stamatovic SM, Keep RF, Andjelkovic AV (2008) Brain endothelial cell-cell
junctions: How to “open” the blood brain barrier. Current Neuropharmacology 6:
179-192.
34. Lanao J, Fraile M (2005) Drug tissue distribution: Study methods and therapeutic
implications. Current Pharmaceutical Design 11: 3829-3845.
64. http://www.worldscientific.com/worldscibooks/10.1142/6454
35. Sjögren E, Abrahamsson B, Augustijns P, Becker D, Bolger MB, et al. (2014) In